EUVIMEDEUVIMED entdecken
Crossref

Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure

Eshat F Haque, Ryosuke Tanino, Tamio Okimoto, Takamasa Hotta, Takae Okuno, Kento Kono, Yukari Tsubata, Takeshi Isobe

Anticancer Research · 2026

DOI: 10.21873/anticanres.18032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Eshat F Haque und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan. Hauptthemen laut MEDLINE: Pemetrexed, Mutation, Protein Kinase Inhibitors, Carcinoma, Non-Small-Cell Lung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PemetrexedMutationProtein Kinase InhibitorsCarcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansErbB ReceptorsAniline CompoundsCell Line, TumorGefitinibDrug Resistance, NeoplasmPyrimidinesIndolesAcrylamides

Stichwörter der Autor:innen

Concurrent therapyEGFR-TKIpemetrexedtumor mutational burden

Substanzen

PemetrexedErbB ReceptorsProtein Kinase InhibitorsAniline CompoundsEGFR protein, humanGefitinibPyrimidinesosimertinibIndolesAcrylamides

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
  • Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan okimoto@med.shimane-u.ac.jp.

Zitieren

APA

Haque, E. F., Tanino, R., Okimoto, T., Hotta, T., Okuno, T., Kono, K., Tsubata, Y., & Isobe, T. (2026). Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure. Anticancer Research. https://doi.org/10.21873/anticanres.18032

Vancouver

Haque EF, Tanino R, Okimoto T, Hotta T, Okuno T, Kono K, et al. Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure. Anticancer Research. 2026. doi:10.21873/anticanres.18032

BibTeX
@article{Haque2026,
  author = {Haque, Eshat F and Tanino, Ryosuke and Okimoto, Tamio and Hotta, Takamasa and Okuno, Takae and Kono, Kento and Tsubata, Yukari and Isobe, Takeshi},
  title = {Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18032}
}
Kostenlos starten →